Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 74.35B | 73.81B | 82.56B | 93.86B | 57.87B | 44.30B |
Gross Profit | 25.69B | 24.35B | 25.65B | 19.33B | 19.00B | 16.22B |
EBITDA | 17.51B | 16.14B | 17.44B | 8.79B | 10.42B | 8.28B |
Net Income | 5.09B | 4.11B | 2.21B | 216.00M | 3.66B | -1.54B |
Balance Sheet | ||||||
Total Assets | 164.73B | 189.54B | 194.64B | 235.49B | 225.33B | 153.18B |
Cash, Cash Equivalents and Short-Term Investments | 15.93B | 17.74B | 17.35B | 16.42B | 14.22B | 13.52B |
Total Debt | 52.20B | 52.01B | 47.29B | 40.59B | 41.05B | 37.94B |
Total Liabilities | 126.41B | 148.09B | 158.92B | 196.21B | 183.35B | 119.33B |
Stockholders Equity | 30.92B | 34.56B | 30.06B | 34.25B | 36.99B | 28.95B |
Cash Flow | ||||||
Free Cash Flow | -8.09B | 3.76B | 5.79B | 2.21B | 1.32B | 2.47B |
Operating Cash Flow | 695.00M | 13.14B | 13.12B | 8.59B | 7.31B | 7.59B |
Investing Cash Flow | -827.00M | -11.34B | -11.82B | -4.29B | -11.04B | -4.05B |
Financing Cash Flow | -1.77B | -1.46B | -218.00M | -2.98B | 4.85B | -562.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $6.46B | 12.59 | 9.81% | 6.05% | -5.28% | 14.50% | |
71 Outperform | $6.06B | 4.73 | 22.94% | 13.55% | -3.27% | -3.44% | |
71 Outperform | $58.85B | 21.84 | 8.87% | 2.83% | 0.46% | -11.77% | |
69 Neutral | $53.01B | 9.60 | 17.61% | 8.63% | 2.35% | 2.25% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | $10.02B | 9.93 | 21.17% | 4.98% | -3.19% | 30.48% | |
64 Neutral | $22.43B | 1,772.16 | 1.06% | 4.89% | 8.86% | ― |